Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The endogenous cannabinoid, anandamide, has been suggested as an endothelium-derived hyperpolarizing factor (EDHF). We found that anandamide-evoked relaxation in isolated segments of rat mesenteric artery was associated with smooth muscle hyperpolarization. However, although anandamide-evoked relaxation was inhibited by either charybdotoxin (ChTX) or iberiotoxin, inhibition of the relaxation to EDHF required a combination of ChTX and apamin. The relaxations induced by either anandamide or EDHF were not inhibited by the cannabinoid receptor (CB1) antagonist SRI41716A, or mimicked by selective CB1 agonists. Thus, anandamide appears to cause smooth muscle relaxation via a CB1 receptor-independent mechanism and cannabinoid receptor activation apparently does not contribute to EDHF-mediated relaxation in this resistance artery.

Original publication




Journal article


Br J Pharmacol

Publication Date





1509 - 1511


Animals, Apamin, Arachidonic Acids, Biological Factors, Cannabinoids, Dose-Response Relationship, Drug, Endocannabinoids, In Vitro Techniques, Male, Mesenteric Arteries, Piperidines, Polyunsaturated Alkamides, Pyrazoles, Rats, Rats, Sprague-Dawley, Rats, Wistar, Receptors, Cannabinoid, Receptors, Drug, Rimonabant, Vasodilation